Sunday, December 2, 2018

Sun Pharma slips 10% as Sebi starts probe; may reopen insider trading case

The stock 10% to Rs 443 on the BSE on reports that the market regulator Sebi has initiated an inquiry into the affairs of pharma major on the basis of a whistle-blower complaint. https://ift.tt/eA8V8J

from Home Page via vilayatimall.com Find Latest Coupons & Offers For Online Shopping Sites.

No comments:

Post a Comment